MEDICINOVA INC
For the period ended Dec 31, 2025. Filed Mar 10, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 10, 2026
MNOV$1.47+0.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Assets: | ||
| Current assets: | ||
| Cash and cash equivalents | $30,806,477 | $40,359,738 |
| Prepaid expenses and other current assets | 184,827 | 714,541 |
| Total current assets | 30,991,304 | 41,074,279 |
| Goodwill | 9,600,240 | 9,600,240 |
| In-process research and development | 4,800,000 | 4,800,000 |
| Property and equipment, net | 8,340 | 25,507 |
| Right-of-use asset | 184,229 | 356,904 |
| Other non-current assets | 18,996 | 18,996 |
| Total assets | $45,603,109 | $55,875,926 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $624,995 | $1,102,494 |
| Accrued liabilities and other current liabilities | 2,608,021 | 1,662,860 |
| Deferred revenue | 370,160 | — |
| Operating lease liability | 194,331 | 193,769 |
| Total current liabilities | 3,797,507 | 2,959,123 |
| Deferred tax liability | 201,792 | 201,792 |
| Other non-current liabilities | 17,129 | 211,460 |
| Total liabilities | 4,016,428 | 3,372,375 |
| Commitments and contingencies (Note 5) | ||
| Stockholders’ equity: | ||
| Common stock, $0.001 par value; 100,000,000 shares authorized at December 31, 2025 and December 31, 2024; 49,221,246 and 49,046,246 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | 49,221 | 49,046 |
| Additional paid-in capital | 480,413,839 | 479,340,901 |
| Accumulated other comprehensive loss | (127,180) | (135,154) |
| Accumulated deficit | (438,749,199) | (426,751,242) |
| Total stockholders’ equity | 41,586,681 | 52,503,551 |
| Total liabilities and stockholders’ equity | $45,603,109 | $55,875,926 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.